Dr. Jim Hu - Robotic Extraperitoneal Radical Prostatectomy Surgical Video With Narration
In this video, Jim C. Hu, MD, MPH presents a case of a patient who had prior surgery and was not offered a robotic assisted radical prostatectomy for prostate cancer. In this presentation, he demonstrates that a safe approach to surgery may be used in men with prior abdominal surgery, as well as men with a higher body mass index.
If you would like an appointment, please call us at (646) 962-9600. Dr. Jim C. Hu goes over some common questions many men have about prostate cancer surgery, a.k.a. radical prostatectomy.
John N. Graham, Jr.
John N. Graham, Jr., M.D. is an Assistant Professor of Urology at Weill Cornell Medicine. He joined the surgical staff after completing the prestigious Felix and Mildred Yip Fellowship in Advanced Robotics, Laparoscopy, and Urologic Oncology at the USC Institute of Urology, University of Southern California, Keck School of Medicine in Los Angeles, California. He completed his residency at the State University of New York, Downstate Medical Center in Brooklyn, New York.
Fatima Z. Husain
Dr. Fatima Z. Husain is a New Jersey native who graduated from Rutgers University and obtained a Master of Public Health, prior to graduating from medical school. She completed urology residency training at Mount Sinai Medical Center in New York, and went on to complete the prestigious and competitive fellowship in Advanced Robotics and Laparoscopy and Urologic Oncology at the University of Southern California, Keck School of Medicine in Los Angeles, California.
Dr. Christopher Barbieri - Genomic Testing For Prostate Cancer Patients
To request an appointment with Dr. Barbieri in NYC, please call (212) 746-5562.
Dr. Barbieri discusses Genomic Testing For Prostate Cancer Patients, and how this may impact risk stratification and decision to pursue treatment(s).
To learn more about Dr. Barbieri, please visit our website at: https://urology.weillcornell.org/christopher-e-barbieri
Dr. Christopher Barbieri - Genetic Testing For Prostate Cancer Risk Assessment
To request an appointment with Dr. Barbieri in NYC, please call (212) 746-5562.
Dr. Christopher Barbieri discusses recent advances in genetic testing that allow patients to have blood or saliva sampled to help evaluate their risk of developing prostate cancer.
To learn more about prostate cancer, please visit our website at: https://urology.weillcornell.org/prostate-cancer
Dr. Jim Hu - Does Prostatectomy Cure Prostate Cancer?
If you would like an appointment, please call us at (646) 962-9600.
Dr. Jim C. Hu discusses various factors that contribute to whether a radical prostatectomy has a curative outcome in any given patient.
To request an appointment with an NYC Urologist specializing in prostate cancer at Weill Cornell Medicine, please visit: https://urology.weillcornell.org/request-appointment
David A. Green
Dr. Green is a urologic surgeon with expertise in the surgical management of urologic cancers. After receiving his M.D. from the Mount Sinai School of Medicine, Dr. Green completed his residency in urology at New York Medical College. He then completed a fellowship in urologic oncology at NewYork-Presbyterian/Weill Cornell Medical Center during which time he authored numerous peer reviewed articles and book chapters on the topics of bladder, kidney, and prostate cancer.
MRI-Ultrasound Fusion Guided Focal Cryotherapy of Prostate Cancer at Weill Cornell Urology
If you would like to make an appointment to see a urologist specializing in prostate cancer, please call our office at (646) 962-9600.
This educational video discusses the MRI-Ultrasound Fusion Guided Focal Cryotherapy of Prostate Cancer, which is an innovative procedure performed at Weill Cornell Medicine.
You can learn more about prostate cancer treatment and Weill Cornell Medicine's expertise by visiting our prostate cancer resources pages.
Research on SPOP Prostate Cancer Subtype Prognosis and PSA levels
Dr. Christopher Barbieri was interviewed as a co-senior author on new prostate cancer research from Weill Cornell Medicine & colleagues, regarding the interpretation of PSA levels in patients with the SPOP prostate cancer subtype.
"These findings are counterintuitive," said co-senior author Dr. Christopher Barbieri, an assistant professor of urology at Weill Cornell Medicine. "In general, if your PSA is higher, the cancer is more dangerous. However, this study found that tumors associated with a high PSA and SPOP mutations were less dangerous."
